comparemela.com

Page 12 - Bloomberg Astrazeneca Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astra-EU Fight Opens New Rift in Global Bid to End Pandemic

A European dispute over supply of Covid-19 vaccines is threatening to unleash a wider political and economic conflict that could stymie global collaboration needed to end the pandemic.

AstraZeneca to Test If Longer Wait Between Vaccine Doses Works Better

AstraZeneca to Test If Longer Wait Between Vaccine Doses Works Better Bloomberg 1/27/2021 Suzi Ring © Bloomberg Vials of Covishield, the local name for the Covid-19 vaccine developed by AstraZeneca Plc. and the University of Oxford, move along a conveyor on the production line at the Serum Institute of India Ltd. Hadaspar plant in Pune, Maharashtra, India, on Friday, Jan. 22, 2021. (Bloomberg) AstraZeneca Plc plans to conduct a global study on the optimal interval between the two doses of its Covid-19 vaccine as questions linger over how to elicit the best protection for the greatest number of people. Popular Searches The new trial will investigate a two-month gap between shots to determine whether it can provide better efficacy, Chief Executive Pascal Soriot told a group of European newspapers Tuesday. The U.K. approved the vaccine, developed with the University of Oxford, last month with a 4- to 12-week dosing interval.

EU-Astra Vaccine Call Back On After Chaotic Morning in Dispute

EU Demands Access to AstraZeneca’s U.K. Vaccine Supplies in Call Bloomberg 1/27/2021 Suzi Ring, Jonathan Stearns and Nikos Chrysoloras (Bloomberg) A chaotic showdown between AstraZeneca Plc and the European Union is coming to a head in a high stakes meeting on Wednesday with EU officials demanding the company tap British production facilities to make up for shortfalls in supply to the continent. The public fight has epitomized the bloc’s failure to put its mass vaccination campaign on the right track, and cast doubt on its hopes to inoculate millions speedily and exit recession-inducing lockdowns. The row was triggered by the drugmaker’s announcement that vaccine deliveries to Europe will be lower than previously anticipated.

EU Demands Access to AstraZeneca s U K Vaccine Supplies in Call

EU Demands Access to AstraZeneca’s U.K. Vaccine Supplies in Call Bloomberg 1/27/2021 Suzi Ring, Jonathan Stearns and Nikos Chrysoloras (Bloomberg) A chaotic showdown between AstraZeneca Plc and the European Union is coming to a head in a high stakes meeting on Wednesday with EU officials demanding the company tap British production facilities to make up for shortfalls in supply to the continent. The public fight has epitomized the bloc’s failure to put its mass vaccination campaign on the right track, and cast doubt on its hopes to inoculate millions speedily and exit recession-inducing lockdowns. The row was triggered by the drugmaker’s announcement that vaccine deliveries to Europe will be lower than previously anticipated.

Thailand Approves AstraZeneca: Southeast Asia Vaccine Tracker

Thailand Approves AstraZeneca: Southeast Asia Vaccine Tracker Bloomberg 1/23/2021 Claire Jiao and Ian Sayson (Bloomberg) AstraZeneca Plc’s vaccine won approval from Thailand, becoming the third company to clear regulatory requirements for use in Southeast Asia. Thousands of people in Singapore and Indonesia have already received the Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd. vaccines, and their neighbors are signing more deals to procure supplies. China is also giving free vaccines to countries like the Philippines and Cambodia. Indonesia, Southeast Asia’s biggest and most populous economy, started its coronavirus vaccination program on Jan. 13, with President Joko Widodo taking the first Sinovac jab as the race to immunize people against Covid-19 gains pace.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.